Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-Ovarian Cancer Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
26-Nov-2020
Consolidation/Split - BD1
25-Nov-2020
Helen Fisher Steps Down from BARD1 Board
23-Nov-2020
BARD1 Gains New High-volume Customer for its hTERT Test
30-Oct-2020
Appendix 4C and Quarterly Activities Report
27-Oct-2020
Notice of Annual General Meeting/Proxy Form
19-Oct-2020
Notice of AGM ASX Listing Rule 3.13.1
23-Sep-2020
Successful BARD1 Kit Evaluation
3-Sep-2020
BARD1 Awarded BTB Funding to Develop Breast Cancer Test
31-Aug-2020
Revised Securities Trading Policy
25-Aug-2020
Appendix 4G and Corporate Governance Statement
Previous
1
2
3
4
5
Next
